Artemin Stimulates Radio- and Chemo-resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells
Open Access
- 1 December 2012
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (51) , 42502-42515
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinomaBreast Cancer Research, 2011
- Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patientsBreast Cancer Research, 2011
- Twist1-Induced Invadopodia Formation Promotes Tumor MetastasisCancer Cell, 2011
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell HypothesisJournal of Oncology, 2010
- TWISTing an embryonic transcription factor into an oncoproteinOncogene, 2010
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cellsOncogene, 2010
- Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 ExpressionNeoplasia, 2009
- Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expressionCancer Science, 2009
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Radioresistance in carcinoma of the breastThe Breast, 2004